NV
Northpond Ventures Portfolio holdings
AUM
$43.7M
This Quarter Return
+35.97%
1 Year Return
-34.02%
3 Year Return
-71.84%
5 Year Return
–
10 Year Return
–
AUM
$55.3M
AUM Growth
+$55.3M
(-46%)
Cap. Flow
-$33.9M
Cap. Flow
% of AUM
-61.4%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
TBIO
Telesis Bio, Inc. Common Stock
TBIO
|
$33.9M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Kyverna Therapeutics
KYTX
$160M
| $24.4M | 44.18% | 3,255,426 | – | – |
|
|
VIGL
2
DELISTED
Vigil Neuroscience
VIGL
| $16.9M | 30.5% | 4,214,498 | – | – |
|
3
Candel Therapeutics
CADL
$318M
| $12M | 21.71% | 1,935,215 | – | – |
|
|
TBIO
4
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
| $2M | 3.61% | 546,897 -9,297,233 | -94% | -$33.9M |
|